| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5605460 | International Journal of Cardiology | 2017 | 34 Pages |
Abstract
Prevalence of malignant diseases is high in TTC patients, and is a risk factor for worse outcome. Screening for malignancies should be recommended in all patients presenting with TTC. Further studies are needed to define the association on molecular levels.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
K. Sattler, I. El-Battrawy, S. Lang, X. Zhou, K. Schramm, E. Tülümen, F. Kronbach, S. Röger, M. Behnes, J. Kuschyk, M. Borggrefe, I. Akin,